# Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome

> **NCT05541003** · PHASE2 · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 12 (actual)

## Conditions studied

- Prader-Willi Syndrome
- Obesity

## Interventions

- **DRUG:** NBT-NM108

## Key facts

- **NCT ID:** NCT05541003
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-06
- **Primary completion:** 2023-05-29
- **Final completion:** 2023-05-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05541003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05541003, "Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05541003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*